Scott Hensley -NPR

A woman in purple gloves look at a shot.

Pfizer-BioNTech COVID vaccine appears more than 90% effective in kids 5 to 11

0
The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side effects and because it still prompts a strong immune response.
A man in a blue shirt puts a shot in the arm of another man.

CDC advisers back rollout of COVID vaccine boosters from Moderna and J&J

0
A panel advising the Centers for Disease Control and Prevention also endorsed a mix-and-match approach to boosters that would be flexible for patients and health care providers.
A health care worker in blue scrubs and wearing a mask prepares a dose of vaccine.

The FDA authorizes Moderna and J&J COVID vaccine boosters

0
The Food and Drug Administration also gave an OK to boosters that differ from the vaccine originally used to immunize people against COVID-19. A mix-and-match approach could ease the booster rollout.
Boxes of the Moderna COVID-19 vaccine sit on a desk.

Moderna and J&J say their data supports COVID vaccine boosters

0
The Food and Drug Administration released briefing documents Tuesday on booster shots for the Moderna and Johnson & Johnson COVID vaccines ahead of a two-day advisory meeting that starts Thursday.

The FDA OKs Pfizer-BioNTech booster for people 65+ and at high risk for severe COVID

0
A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.
A person holds out a shot.

Pfizer’s COVID vaccine gets full approval from the FDA

0
The Food and Drug Administration has formally approved Pfizer's COVID-19 vaccine. The widely anticipated decision replaces the emergency use authorization granted by the agency last December.